![Hendrik Nogai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hendrik Nogai
Directeur Technique/Scientifique/R&D chez
RYVU THERAPEUTICS S.A.
Fortune : 88 596 $ au 31/07/2026
Profil
Dr. Hendrik Nogai, MD, is a Chief Medical Officer at Ryvu Therapeutics SA. Dr. Nogai was previously employed as a Vice President by Bayer Pharmaceuticals /Switzerland/.
He received his doctorate degree from Ludwig-Maximilians-Universität München, a doctorate degree from Charité - Universitätsmedizin Berlin and a doctorate degree from Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2025 | 22 500 ( 0,1% ) | 88 596 $ | 31/07/2026 |
Postes actifs de Hendrik Nogai
| Sociétés | Poste | Début |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Directeur Technique/Scientifique/R&D | 01/02/2022 |
Anciens postes connus de Hendrik Nogai
| Sociétés | Poste | Fin |
|---|---|---|
Bayer Pharmaceuticals /Switzerland/ | Corporate Officer/Principal | 01/01/2022 |
Formation de Hendrik Nogai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Charité - Universitätsmedizin Berlin
 Charité - Universitätsmedizin Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ryvu Therapeutics SA
 Ryvu Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and sells therapies for precision oncology | Health Technology |
Bayer Pharmaceuticals /Switzerland/ |
